AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
23.39
-0.43 (-1.81%)
At close: Jun 18, 2025, 4:00 PM
23.50
+0.11 (0.47%)
After-hours: Jun 18, 2025, 5:26 PM EDT
AnaptysBio Market Cap
AnaptysBio has a market cap or net worth of $687.21 million as of June 18, 2025. Its market cap has increased by 7.18% in one year.
Market Cap
687.21M
Enterprise Value
693.23M
1-Year Change
7.18%
Ranking
Category
Stock Price
$23.39
Market Cap Chart
Since January 26, 2017, AnaptysBio's market cap has increased from $308.70M to $687.21M, an increase of 122.61%. That is a compound annual growth rate of 10.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 687.20M | 70.56% |
| Dec 31, 2024 | 402.90M | -29.22% |
| Dec 29, 2023 | 569.20M | -35.40% |
| Dec 30, 2022 | 881.10M | -7.83% |
| Dec 31, 2021 | 955.90M | 62.57% |
| Dec 31, 2020 | 588.00M | 33.36% |
| Dec 31, 2019 | 440.90M | -74.16% |
| Dec 31, 2018 | 1.71B | -27.90% |
| Dec 29, 2017 | 2.37B | 666.67% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 704.75B |
| Johnson & Johnson | 362.67B |
| Novo Nordisk | 331.06B |
| AbbVie | 327.65B |
| UnitedHealth Group | 278.67B |
| Abbott Laboratories | 230.37B |
| Novartis AG | 227.75B |
| AstraZeneca | 220.36B |